The themes Envista is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
売上構成比はsix months ended July 3, 2026の推計であり、提出された報告書の数字ではありません。
Dental implant systems and related products
Systems for replacing missing teeth, including implants, guided-surgery products, bone-regeneration materials, and tooth restorations. Brands include Nobel Biocare, Alpha-Bio Tec, and Implant Direct.
DTX Studio software
Software that helps dental professionals review patient images and plan implant procedures and restorations.
Orthodontic brackets, wires, and related products
Products orthodontists use to move teeth, including brackets, wires, tubes, bands, retainers, and laboratory products. Brands include Ormco and Damon.
Spark clear aligners
Removable clear trays used to straighten teeth, with software for planning and reviewing treatment.
Dental imaging equipment
Dental X-ray systems, digital sensors, and intraoral scanners used to capture images of patients’ teeth and mouths. Brands include DEXIS and i-CAT.
Dental consumables and infection-prevention products
Materials and tools used in routine dental care, including restorative materials, root-canal products, burs, bonding agents, cements, and surface disinfectants. Brands include Kerr, Sybron Endo, and Metrex.
Envista makes products used to diagnose, treat, and prevent problems with teeth and gums, and to improve smiles. It sells to general dentists, dental specialists, orthodontists, dental laboratories, and dental groups, directly and through distributors. Its products range from dental imaging and treatment-planning software to tooth-replacement systems, braces, restorative materials, root-canal products, and disinfectants.
Envista Holdings Corporation 自身が米国証券取引委員会(SEC)に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。
NVST · NYSE · Healthcare · Medical Instruments and Supplies
$24.66-2.5%11月12日 終値
2026年10月2日までの数値(2026年11月4日提出の10-Qより)
Envista makes dental implants, orthodontic braces and clear aligners, dental imaging equipment and software, and materials used in dental care.
Just reported
From Envista's results release of 2026年11月4日; its quarterly report has since been filed.
Actual
$691.5M
+3.2% y/y
-5.3% q/q
Guided
—
No guide given
Actual
$3.11
Guided
—
No guide given
EPS, adjusted: $0.40
Actual
$515.2M
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Grade B+
株価の下の帯は各日付時点の評価で、その時点までに公開された書類だけで算出しています。
Envista Holdings Corporation の評価履歴 28 四半期のうち 2 四半期を表示しています。 残る 26 四半期は 2020年2月 まで遡ります。